DiaSorin SpA
OTC:DSRLF

Watchlist Manager
DiaSorin SpA Logo
DiaSorin SpA
OTC:DSRLF
Watchlist
Price: 83.68 USD Market Closed
Market Cap: $4.5B

Operating Margin

22.8%
Current
Declining
by 0.1%
vs 3-y average of 22.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
22.8%
=
Operating Income
€342.5m
/
Revenue
€1.5B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
22.8%
=
Operating Income
$342.5m
/
Revenue
€1.5B

Peer Comparison

Country Company Market Cap Operating
Margin
IT
DiaSorin SpA
MIL:DIA
3.9B EUR
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.6B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
186.9B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
138.7B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.1B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
130.7B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.5B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.9B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.8B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.5B USD
Loading...

Market Distribution

Higher than 84% of companies in Italy
Percentile
84rd
Based on 1 199 companies
84rd percentile
22.8%
Low
-79 476% — 3.9%
Typical Range
3.9% — 14.4%
High
14.4% — 813.7%
Distribution Statistics
Italy
Min -79 476%
30th Percentile 3.9%
Median 8.7%
70th Percentile 14.4%
Max 813.7%

DiaSorin SpA
Glance View

In the heart of the global healthcare landscape, DiaSorin SpA stands as a testament to innovation and precision in the field of biotechnology. Founded in 1968 in Italy, the company built its reputation on developing and producing diagnostic tests that help identify and monitor diseases. With a primary focus on immunodiagnostic and molecular diagnostic products, DiaSorin excels in creating high-quality, reliable solutions that clinicians and labs around the world depend on. Their product portfolio ranges widely, covering infectious diseases, oncology, endocrinology, and more. By leveraging cutting-edge research and development processes, DiaSorin not only prioritizes accuracy and efficiency in its testing solutions but also adapts to the ever-evolving demands of the medical world, cementing its role as a leader in diagnostic innovation. From a business perspective, DiaSorin's revenue streams are deeply intertwined with its prowess in developing proprietary testing technologies, including both instruments and consumables. The company operates with a dual-channel business model where it sells diagnostic machines to laboratories, hospitals, and clinics while simultaneously providing the reagents and kits necessary for these machines' continuous operation. This approach ensures not only a sale of sophisticated equipment but also a recurring revenue stream from the consumables needed for diagnostics. With a strategic emphasis on research and partnerships, DiaSorin has expanded its reach globally, ensuring its products meet diverse regional healthcare requirements. Through a combination of robust product offerings and strategic global expansion, DiaSorin continues to thrive and maintain its position as a pivotal contributor to the field of diagnostic medicine.

DSRLF Intrinsic Value
120.38 USD
Undervaluation 30%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
22.8%
=
Operating Income
€342.5m
/
Revenue
€1.5B
What is DiaSorin SpA's current Operating Margin?

The current Operating Margin for DiaSorin SpA is 22.8%, which is below its 3-year median of 22.9%.

How has Operating Margin changed over time?

Over the last 3 years, DiaSorin SpA’s Operating Margin has decreased from 30.3% to 22.8%. During this period, it reached a low of 20.7% on Dec 31, 2023 and a high of 30.3% on Jun 30, 2022.

Back to Top